NEW - TPD & Induced-Proximity Drug Discovery Training courses now available

Expand your team's knowledge of this rapidly-expanding and fast-moving field of drug discovery

We offer customizable awareness & training courses suited to your needs ranging from a 1 hour overview through to whole day or multi-session training including interactive workshops. For an overview of the topics covered and focus areas described, please download our training overview brochure here

Training is suitable for groups of up to 100 or more who are new to TPD & induced-proximity drug discovery as well as any groups wanting a refresher of contemparary thinking and advances in this fast-moving field.

For further details and to discuss a customized course outline, please contact us at

What we offer

With extensive experience gained from over 25 years in biotech and pharma across many areas including new modality development, AI in drug discovery, targeted protein degradation & bifunctional agents as well as small molecule discovery across multiple therapeutic areas including oncology, neuroscience, immunology and others, Janus has a wide breadth of experience to help your drug discovery projects advance through target selection, hit identification & optimisation through to selection of candidates for further development.


targeted protein degradation and artificial intelligence AI

Working closely with management teams on strategic plan definition and delivery

Whether your company is forming, in stealth phase, growing fast or have key pre-clinical value creation points upcoming, Janus can work with your leadership team to help define strategy, refine plans and review data at a portfolio or project level.


We can identify the data and capabilities which make the most compelling story for bringing in new investment and work alongside your team to build the narrative around your exciting ideas and data.

  • Strategy setting
  • Refinement of USP & company narrative for investment
  • Data review
  • Direct portfolio & project oversight and input
    • Target selection
    • Molecule optimisation
    • Milestone data package creation and refinement
  • Resource utilization reviews
  • Hiring of key staff
Ian Churcher advisor, board

Acting as advisor, mentor, SAB member or NED

All high performing teams can benefit from a second pair of eyes bringing new perspective, suggestions and contacts. 


Janus can work with boards and leadership teams to give regular review and input to strategies and plans through mentorship, scientific advisory boards or through direct contribution to boards in a non-executive role.

  • Membership of Scientific Advisory Boards
  • Working directly with key leaders in a mentoring role
  • Direct interactions at board level through non-executive roles
venture capital and private equity

Working with investors on company creation, seed phase strategy or due diligence activities

The most exciting time for a company can be right at the start when ideas turn into the first tangible data to show the potential. This phase is crucial as generating the right data quickly, often with only a tiny team of founders, can unlock further investment and rapid growth so decisions made here are crucial. 


Janus can help investors as you think about company creation and seed phase activities in areas which require application to drug discovery bringing skillsets that complement the academic founders.


Alternatively, you may be considering investment in a more mature company and require due diligence input of pre-clinical drug discovery, chemical or biological datasets – Janus can help you here too.

  • Working with investors to develop plans for seed phases
  • Working with academic founders to bring drug discovery perspective to plans
  • Offering expert due diligence services for a range of potential transactions

We need your consent to load the translations

We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.